Form 4: Artivion Director Jeffrey Burbank Receives Stock Grant

Director Jeffrey H. Burbank acquired 7,576 shares of Artivion, Inc. common stock via an equity incentive grant.

Summary

• Director Jeffrey H. Burbank was granted 7,576 shares of common stock.
• The transaction occurred on May 18, 2026.
• The shares were acquired at a price of $0 as part of an equity incentive plan.
• Following this transaction, Mr. Burbank's total beneficial ownership is 61,372 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None.

Risks

• None.

Future Outlook

The granted shares are scheduled to vest on May 18, 2027, subject to the terms of the company's Equity and Cash Incentive Plan.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term performance and align leadership with shareholder interests in the medical device sector.

Comparison to Industry Standards

• The grant is consistent with standard equity compensation practices for non-employee directors in the healthcare and medical technology industries.

Stakeholder Impact

• Minor dilution impact, though typical for standard director compensation packages.

Next Steps

• Vesting of the 7,576 shares on May 18, 2027.

Key Dates

Keywords

Artivion, AORT, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation